The pharmacokinetic and pharmacodynamic properties of site‐specific pegylated genetically modified recombinant human interleukin‐11 in normal and thrombocytopenic monkeys
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Pharmaceutics and Biopharmaceutics"
DOI: 10.1016/j.ejpb.2017.05.013
Abstract: Graphical abstract Figure. No Caption available. Abstract In order to improve the pharmacokinetic and pharmacodynamic properties of recombinant human interleukin‐11 mutein (mIL‐11) and to reduce the frequency of administration, we examined the feasibility of chemical… read more here.
Keywords: pharmacodynamic properties; recombinant human; normal thrombocytopenic; mil ... See more keywords